Marques Tiago Insider Trades

Insider Trading History

Track insider trading activity for Marques Tiago. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $14.2k 1,756,069 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5k 1,756,069 shares
$0.01
$0.01
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $846k 1,756,069 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.48M 1,756,069 shares
$0.84
$0.48
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $35.3k 73,334 shares
Last Trade
Nov 28, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49k 33,333 shares
$1.47
$0.48
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $594 73,334 shares
Last Trade
Nov 28, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.97k 33,333 shares
$0.06
$0.01
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $4k 493,341 shares
Last Trade
Oct 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.97k 493,341 shares
$0.01
$0.01
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $238k 493,341 shares
Last Trade
Oct 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$355k 493,341 shares
$0.72
$0.48
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $324 40,001 shares
Last Trade
May 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$20.9 960 shares
$0.02
$0.01
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $19.3k 40,001 shares
Last Trade
May 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$797 960 shares
$0.83
$0.48
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $7.23k 15,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$217k 26,669 shares
$8.13
$0.48
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $7.23k 15,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 26,669 shares
$8.34
$0.48
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $122 15,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$477 26,669 shares
$0.02
$0.01
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $122 15,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$477 26,669 shares
$0.02
$0.01
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $395k 819,206 shares
Last Trade
Nov 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.4k 2,000 shares
$20.20
$0.48
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $6.64k 819,206 shares
Last Trade
Nov 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136 2,000 shares
$0.07
$0.01
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $394k 817,206 shares
Last Trade
Nov 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 7,206 shares
$20.40
$0.48
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $6.62k 817,206 shares
Last Trade
Nov 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$288 7,206 shares
$0.04
$0.01
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $390k 810,000 shares
Last Trade
Oct 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$106k 5,000 shares
$21.20
$0.48
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $6.56k 810,000 shares
Last Trade
Oct 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405 5,000 shares
$0.08
$0.01
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Executive Officer
Holding Value $387k 802,900 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.8k 2,900 shares
$19.60
$0.48
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Executive Officer
Holding Value $6.5k 802,900 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179 2,900 shares
$0.06
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up